PL2872126T3 - Plaster farmaceutyczny do przezskórnego podawania tapentadolu - Google Patents

Plaster farmaceutyczny do przezskórnego podawania tapentadolu

Info

Publication number
PL2872126T3
PL2872126T3 PL13737149T PL13737149T PL2872126T3 PL 2872126 T3 PL2872126 T3 PL 2872126T3 PL 13737149 T PL13737149 T PL 13737149T PL 13737149 T PL13737149 T PL 13737149T PL 2872126 T3 PL2872126 T3 PL 2872126T3
Authority
PL
Poland
Prior art keywords
tapentadol
transdermal administration
pharmaceutical patch
patch
pharmaceutical
Prior art date
Application number
PL13737149T
Other languages
English (en)
Inventor
Ingo Friedrich
Martin MIKYNA
Sandra GEDAT
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of PL2872126T3 publication Critical patent/PL2872126T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
PL13737149T 2012-07-16 2013-07-15 Plaster farmaceutyczny do przezskórnego podawania tapentadolu PL2872126T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261671975P 2012-07-16 2012-07-16
EP12005221 2012-07-16
EP13737149.8A EP2872126B1 (en) 2012-07-16 2013-07-15 Pharmaceutical patch for transdermal administration of tapentadol
PCT/EP2013/002096 WO2014012653A1 (en) 2012-07-16 2013-07-15 Pharmaceutical patch for transdermal administration of tapentadol

Publications (1)

Publication Number Publication Date
PL2872126T3 true PL2872126T3 (pl) 2018-06-29

Family

ID=49948307

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13737149T PL2872126T3 (pl) 2012-07-16 2013-07-15 Plaster farmaceutyczny do przezskórnego podawania tapentadolu

Country Status (6)

Country Link
US (2) US20150148759A1 (pl)
EP (1) EP2872126B1 (pl)
ES (1) ES2661911T3 (pl)
HU (1) HUE035512T2 (pl)
PL (1) PL2872126T3 (pl)
WO (1) WO2014012653A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016009063A1 (en) 2014-07-18 2016-01-21 Buzzz Pharmaceuticals Limited Oxymorphone transdermal patch
EA034204B1 (ru) * 2014-10-17 2020-01-16 Фидия Фармачеутичи С.П.А. Дермальная терапевтическая система с высокой адгезивной способностью
KR20210005623A (ko) * 2018-04-25 2021-01-14 신케이 테라퓨틱스 엘엘씨 테트라베나진 경피 전달 장치
CN112673136B (zh) 2018-09-10 2023-06-09 阿尔特弥斯智能动力有限公司 带有液压机控制器的设备
MX2021012709A (es) 2019-04-17 2022-01-24 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145511A (en) * 1977-09-01 1979-03-20 The B. F. Goodrich Company Hydroxyl-containing liquid polymers and pressure-sensitive adhesives and laminates prepared therefrom
CA2031376A1 (en) * 1989-12-04 1991-06-05 Bahram Farhadieh Single layer transdermal drug administration system
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
DE102005011517A1 (de) * 2005-03-10 2006-09-21 Grünenthal GmbH Transdermales therapeutisches System zur Verabreichung von Analgetika
US20070072986A1 (en) * 2005-09-23 2007-03-29 Allison Luciano Acrylic polymer-based adhesives
AU2009340504A1 (en) 2008-10-30 2010-08-26 Grunenthal Gmbh Novel and potent tapentadol dosage forms
US20120277695A1 (en) 2010-03-30 2012-11-01 Jeremy Cottrell Transdermal delivery patch

Also Published As

Publication number Publication date
US20150148759A1 (en) 2015-05-28
WO2014012653A1 (en) 2014-01-23
EP2872126A1 (en) 2015-05-20
US20170128388A1 (en) 2017-05-11
ES2661911T3 (es) 2018-04-04
EP2872126B1 (en) 2017-12-06
HUE035512T2 (en) 2018-05-02

Similar Documents

Publication Publication Date Title
HK1205690A1 (en) Pharmaceutical composition and administration thereof
ZA201502352B (en) Liposomal drug delivery system
EP2680918A4 (en) TRANSDERMAL STAMP CONTAINING MICROARRAYS
EP2897598A4 (en) TRANSDERMIC DRUG DELIVERY DEVICE
ZA201307862B (en) Controlled release pharmaceutical dosage forms
HK1204564A1 (en) Topical ophthalmological pharmaceutical composition containing axitinib
PL2616133T3 (pl) Aparaty do podawania leków przez skórę
HK1205146A1 (en) Pharmaceutical formulation
IL236465A0 (en) Pharmaceutical composition for delayed release of active substances
ZA201405797B (en) Pharmaceutical dosage form
AP2015008208A0 (en) Pharmaceutical administration forms comprising
PL2872126T3 (pl) Plaster farmaceutyczny do przezskórnego podawania tapentadolu
HK1205683A1 (en) Pharmaceutical formulation having improved stability
EP2898912A4 (en) INSTRUMENT FOR MEDICINE ADMINISTRATION
IL227651A (en) Topical pharmacological formulations containing 220b
HK1206269A1 (en) Pharmaceutical formulation comprising bendamustine
EP2851074A4 (en) ANALGETIC PHARMACEUTICAL COMPOSITION
ZA201306823B (en) Excipient system for topical delivery of pharmaceutical agents
EP2873422A4 (en) PHARMACEUTICAL PREPARATION FOR INJECTION
ZA201502354B (en) Pharmaceutical dosage form
GB201213729D0 (en) Manufacture of insoluble drugs
GB201109291D0 (en) Muco-adhesive tablet for systemic administration of insulin
GB201301179D0 (en) Pharmaceutical composition comprising opioid analgesic